42. Polyarteritis nodosa Clinical trials / Disease details
Clinical trials : 15 / Drugs : 26 - (DrugBank : 16) / Drug target genes : 26 - Drug target pathways : 105
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00001457 (ClinicalTrials.gov) | September 1995 | 3/11/1999 | Lamivudine for Chronic Hepatitis B | Lamivudine for Chronic Hepatitis B | Chronic Hepatitis B;Chronic Hepatitis D;Glomerulonephritis;Polyarteritis Nodosa | Drug: Lamivudine | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NULL | Completed | N/A | N/A | Both | 60 | Phase 2 | United States |